Latest Janssen Pharmaceutica Stories
The Firm is actively filing Risperdal lawsuits in this proceeding on behalf of men and boys who allegedly developed gynecomastia due to its use. New York, New
The Firm is currently representing numerous men and boys in Risperdal lawsuits that also allege the drug caused gynecomastia, a condition marked by the excessive breast growth in male patients.
The Firm is representing numerous men and boys in Risperdal lawsuits, all of whom allegedly developed gynecomastia (male breast growth) due to an elevation of prolactin caused by Risperdal.
Publication of the study comes amid numerous Risperdal lawsuit filings that allege the medication caused gynecomastia in men and boys. New York, New York (PRWEB)
HPPI to commence Phase IIb study in first quarter 2015 of SUBA(TM)-Itraconazole for treatment of basal cell carcinoma in patients with basal cell carcinoma nevus syndrome TAMPA, Fla.
CUPERTINO, Calif., Dec. 16, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it has entered into an agreement with Santen Pharmaceutical Co., Ltd.
The Firm is currently representing men and young boys in Risperdal lawsuits that allege male gynecomastia allegedly resulting from their use of the antipsychotic medication. New
The Firm is representing numerous men and boys in Risperdal gynecomastia claims that also raise questions about the manner in which the atypical antipsychotic drug was marketed. New
The Firm is representing numerous Risperdal lawsuit plaintiffs who allegedly developed gynecomastia (male breast growth) due to their use of the medication. New
The Firm is representing numerous clients who have filed Risperdal lawsuits after allegedly developing gynecomastia, or male breast growth, due to the antipsychotic medication. New
- To give a box on the ear to.